Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignancies, Non-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00274443
What this trial is testing

An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With Carboplatin

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Celgene 250
Testing effectiveness (Phase 2)Looking for participantsNCT07286149
What this trial is testing

A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)

Who this might be right for
Lung Neoplasm Malignant
Merck Sharp & Dohme LLC 140
Testing effectiveness (Phase 2)UnknownNCT00270582
What this trial is testing

Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Far Eastern Memorial Hospital 58
Not applicableStudy completedNCT01099124
What this trial is testing

Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 25
Large-scale testing (Phase 3)Study completedNCT03351361
What this trial is testing

Nivolumab and Ipilimumab Versus Chimiotherapy in First Line Treatment in PS 2 or Elderly in Advanced NSCLC Patients

Who this might be right for
Advanced Non Small Cell Lung Cancer
Rennes University Hospital 217
Not applicableStudy completedNCT02679170
What this trial is testing

Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS)

Who this might be right for
Non-Small Cell Lung Cancer
Pfizer 692
Testing effectiveness (Phase 2)UnknownNCT05284994
What this trial is testing

TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Nonsmall-cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT03141359
What this trial is testing

Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC

Who this might be right for
Lung Cancer Stage IILung Cancer Stage IIINon Small Cell Lung Cancer
Wake Forest University Health Sciences 61
Early research (Phase 1)Study completedNCT00738751
What this trial is testing

Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers

Who this might be right for
Lung CancerHead and Neck Cancer
H. Lee Moffitt Cancer Center and Research Institute 44
Large-scale testing (Phase 3)UnknownNCT00300729
What this trial is testing

Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy

Who this might be right for
Non-Small Cell Lung Cancer
University Hospital, Linkoeping 319
Testing effectiveness (Phase 2)Ended earlyNCT00290537
What this trial is testing

Phase II Study of ZD6474 in Advanced NSCLC

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07827261
What this trial is testing

BL-B01D1 Combined With Glecirasib in Patients With KRAS G12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 36
Testing effectiveness (Phase 2)Looking for participantsNCT06147570
What this trial is testing

HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 62
Large-scale testing (Phase 3)Study completedNCT00112294
What this trial is testing

Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
Eli Lilly and Company 755
Large-scale testing (Phase 3)Not Yet RecruitingNCT07754123
What this trial is testing

Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLC

Who this might be right for
Advanced or Metastatic NSCLC
Jiangsu Hansoh Pharmaceutical Co., Ltd. 206
Testing effectiveness (Phase 2)Study completedNCT00818441
What this trial is testing

Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

Who this might be right for
Carcinoma, Non-small Cell
Pfizer 119
Large-scale testing (Phase 3)Looking for participantsNCT07416994
What this trial is testing

Pivotal Study to Evaluate YL202 Versus Docetaxel in Patients With Locally Advanced or Metastatic EGFR Sensitive Mutation Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
MediLink Therapeutics (Suzhou) Co., Ltd. 440
Not applicableUnknownNCT03376191
What this trial is testing

Apatinib in Advanced Non-squamous，NSCLC

Who this might be right for
Non-squamous Non-Small Cell Lung Cancer
Jian Fang 100
Not applicableStudy completedNCT04947683
What this trial is testing

Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in Brazil

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Latin American Cooperative Oncology Group 101
Testing effectiveness (Phase 2)Study completedNCT00408460
What this trial is testing

Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Malignant Pleural EffusionRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more
University of Washington 34
Next Page